Drug intelligence / Profile preview

RA1115-B1

Development stage
Unknown
Lead developer
Suzhou Ruiming New Drug Research & Development
Modality
Small Molecules
Administration
Ophthalmic, Topical
01

Overview

RA1115-B1 is a topical ophthalmic eye drop formulation being developed by Suzhou Raymon Pharmaceuticals for the treatment of wet age-related macular degeneration (wAMD). It is designed to provide a non-invasive alternative to the current standard of care, which involves intravitreal injections of anti-VEGF agents. Phase 1 clinical trials in China were completed in August 2023, demonstrating the feasibility of the drug's penetration to the fundus when administered topically. While the specific molecular target and mechanism of action have not been disclosed, the drug represents a significant innovation in the delivery of therapies for retinal diseases, potentially improving patient compliance and reducing the risks associated with invasive ocular injections.

Other names
RA1115RA-1115RA 1115
02

Targets

Beyond the preview

Go deeper on RA1115-B1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RA1115-B1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call